GeneTex

  • Country / Location Selection

United States (US)

FLT3 antibody [BV10A4] (PE)

Cat. No. GTX80209

Host

 Mouse

Clonality

 Monoclonal

Clone Name

 BV10A4

Isotype

 IgG1

Application

 FACS

Reactivity

 Human
Package
100 test ($329)
See all FLT3 products

APPLICATION

Application Note

*Optimal dilutions/concentrations should be determined by the researcher.
Application Recommended Dilution
FACS 20 μl reagent / 100 μl of whole blood or 10⁶ cells in a suspension
Not tested in other applications.

Calculated MW

113 kDa. ( Note )

Product Note

We do not recommend use of this product for Mouse samples.

PROPERTIES

Form

Liquid

Buffer

PBS

Preservative

15mM Sodium azide

Storage

Store as concentrated solution. Centrifuge briefly prior to opening vial. Store at 4ºC. DO NOT FREEZE. Protect from light.

Concentration

Batch dependent (Please refer to the vial label for the specific concentration.)

Antigen Species

Human

Immunogen

BV-173 leukemic cell line

Purification

Purified by size-exclusion chromatography

Conjugation

Phycoerythrin (PE) Wavelength

Note

For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.

TARGET

Synonyms

CD135 , FLK2 , FLT3 , STK1 , fms related tyrosine kinase 3

Cellular Localization

Membrane,Endoplasmic reticulum lumen

Background

This gene encodes a class III receptor tyrosine kinase that regulates hematopoiesis. This receptor is activated by binding of the fms-related tyrosine kinase 3 ligand to the extracellular domain, which induces homodimer formation in the plasma membrane leading to autophosphorylation of the receptor. The activated receptor kinase subsequently phosphorylates and activates multiple cytoplasmic effector molecules in pathways involved in apoptosis, proliferation, and differentiation of hematopoietic cells in bone marrow. Mutations that result in the constitutive activation of this receptor result in acute myeloid leukemia and acute lymphoblastic leukemia. [provided by RefSeq, Jan 2015]

Database

Research Area

REFERENCE

There are currently no references for FLT3 antibody [BV10A4] (PE) (GTX80209). Be the first to share your publications with this product.
Submit a Reference

REVIEW

There are currently no reviews for FLT3 antibody [BV10A4] (PE) (GTX80209). Be the first to share your experience with this product.
Submit a Review
SDS
PBS.pdf
Sodium Azide.pdf
Package List Price ($)
$ 329